These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21188654)

  • 1. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra coronary freshly isolated bone marrow cells transplantation improve cardiac function in patients with ischemic heart disease.
    Bozdag-Turan I; Turan RG; Ludovicy S; Akin I; Kische S; Schneider H; Rehders TC; Turan CH; Arsoy NS; Hermann T; Paranskaya L; Ortak J; Kohlschein P; Bastian M; Sahin K; Nienaber CA; Ince H
    BMC Res Notes; 2012 Apr; 5():195. PubMed ID: 22534049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
    Turan RG; Bozdag-T I; Turan CH; Ortak J; Akin I; Kische S; Schneider H; Rauchhaus M; Rehders TC; Kleinfeldt T; Belu C; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Chatterjee T; Sahin K; Nienaber CA; Ince H
    J Cell Mol Med; 2012 Apr; 16(4):852-64. PubMed ID: 21707914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Rehders TC; Turan CH; Rauchhaus M; Kleinfeldt T; Chatterjee T; Sahin K; Nienaber CA; Ince H
    Circ J; 2011; 75(3):683-91. PubMed ID: 21266786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease.
    Bozdag-Turan I; Turan RG; Paranskaya L; Arsoy NS; Turan CH; Akin I; Kische S; Ortak J; Schneider H; Ludovicy S; Hermann T; D'Ancona G; Durdu S; Akar AR; Ince H; Nienaber CA
    J Transl Med; 2012 Jul; 10():143. PubMed ID: 22776510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
    Assmus B; Schächinger V; Teupe C; Britten M; Lehmann R; Döbert N; Grünwald F; Aicher A; Urbich C; Martin H; Hoelzer D; Dimmeler S; Zeiher AM
    Circulation; 2002 Dec; 106(24):3009-17. PubMed ID: 12473544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
    Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
    Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
    Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
    J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
    Schutt RC; Trachtenberg BH; Cooke JP; Traverse JH; Henry TD; Pepine CJ; Willerson JT; Perin EC; Ellis SG; Zhao DX; Bhatnagar A; Johnstone BH; Lai D; Resende M; Ebert RF; Wu JC; Sayre SL; Orozco A; Zierold C; Simari RD; Moyé L; Cogle CR; Taylor DA;
    Circ Res; 2015 Jan; 116(1):99-107. PubMed ID: 25406300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
    Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction.
    Obradović S; Rusović S; Balint B; Ristić-Andelkov A; Romanović R; Baskot B; Vojvodić D; Gligić B
    Vojnosanit Pregl; 2004; 61(5):519-29. PubMed ID: 15551805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
    Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
    Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcoronary transplantation of progenitor cells after myocardial infarction.
    Assmus B; Honold J; Schächinger V; Britten MB; Fischer-Rasokat U; Lehmann R; Teupe C; Pistorius K; Martin H; Abolmaali ND; Tonn T; Dimmeler S; Zeiher AM
    N Engl J Med; 2006 Sep; 355(12):1222-32. PubMed ID: 16990385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.